Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, and is used to treat upper gastrointestinal bleeding; reduces the blood flow to visceral organs without significantly changing the systemic arterial blood pressure, and is suitable for the treatment of esophageal varicose bleeding; reduces the endocrine and related functions of the pancreas.

Improves the body's metabolism, participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides, and is also a source of energy in the body

It plays an important role in the metabolism of sugar, fat and protein, and is closely related to the synthesis of acetylcholine, the accumulation of liver glycogen, the reduction of cholesterol and the regulation of blood lipid content.

It has the effects of lowering blood sugar, inhibiting glycogenolysis and glycogenolysis, promoting muscle and adipose tissue to absorb glucose and amino acids, and promoting the decomposition of very low-density lipoprotein.

Diclofenac sodium is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid to prostaglandins. At the same time, it can also promote the combination of arachidonic acid and triglycerides, reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac sodium is a stronger non-steroidal anti-inflammatory drug. Its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

This product is a diphenylpiperazine calcium channel blocker with selective cerebral vasodilation.